Gene therapy for spinal cord injury and disease

Journal of Spinal Cord Medicine

Volumn 25, Issue 1, 2002, Pages 2-9

  Poulsen, David J ^a   Harrop, James S ^b   During, Matthew J ^b  

^a UNIVERSITY OF MONTANA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Chronic neuropathic pain; Gene therapy; Nonviral vectors; Spinal cord injuries; Transgene expression; Viral vectors

Indexed keywords

ADENOVIRUS VECTOR; BETA ENDORPHIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GALANIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; NEUROTROPHIC FACTOR; PLASMID DNA; PROTEIN BCL 2; RETROVIRUS VECTOR; SOMATOMEDIN C; VIRUS DNA; VIRUS VECTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CELL BASED GENE THERAPY; CELL SURVIVAL; CYTOTOXICITY; DNA SEQUENCE; DNA VECTOR; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS VECTOR; HUMAN; IMMUNE RESPONSE; NERVE FIBER GROWTH; NEUROPATHIC PAIN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLIOMYELITIS VIRUS VECTOR; REVIEW; SPINAL CORD DISEASE; SPINAL CORD INJURY; VIRAL GENE DELIVERY SYSTEM; GENETICS; PATHOLOGY;

GENE THERAPY; HUMANS; SPINAL CORD DISEASES; SPINAL CORD INJURIES;

EID: 0036511904     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2002.11753594     Document Type: Review

References (75)

1. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther. 1996;7: 1947-1954.
2. Schwartz B, Benoist C, Abdallah B, et al. Gene transfer by naked DNA into adult mouse brain. Gene Ther. 1996;3:405-411.
3. Schwartz B, Benoist C, Abdallah B, Scherman D, Behr JP, Demeneix BA. Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio. Hum Gene Ther. 1995;6:1515-1524.
4. Martinez-Fong D, Navarro-Quiroga I, Ochoa I, et al. Neurotensin-SPDP-poly-L-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells. Brain Res Mol Brain Res. 1999;69:249-262.
5. Meuli-Simmen C, Liu Y, Yeo TT, et al. Gene expression along the cerebral-spinal axis after regional gene delivery. Hum Gene Ther. 1999;10:2689-2700.
6. Takahashi K, Schwarz E, Ljubetic C, Murray M, Tessler A, Saavedra RA. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats. J Comp Neurol. 1999;404: 159-171.
7. Fields BNK, Knipe DM, Chanock RM, et al. In: Fields BN, DMK, eds. 2nd ed. New York, NY: Raven Press; 1991: 409-450.
8. Khromykh AA. Replicon-based vectors of positive strand RNA viruses. Curr Opin Mol Ther. 2000;2:555-569.
9. Porter DC, Wang J, Moldoveanu Z, McPherson S, Morrow CD. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Vaccine. 1997;15:257-264.
10. Bledsoe AW, Jackson CA, McPherson S, Morrow CD. Cytokine production in motor neurons by poliovirus replicon vector gene delivery. Nat Biotechnol. 2000;18:964-969.
11. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA. 1996;93:11382-11388.
12. Lever AM. Lentiviral vectors: progress and potential. Curr Opin Mol Ther. 2000;2:488-496.
13. Glorioso JC, Bender MA, Goins WF, Fink DJ, DeLuca N. HSV as a gene transfer vector for the nervous system. Mol Biotechnol. 1995;4:87-99.
14. Kennedy PG. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain. 1997;120: 1245-1259.
15. Keir SD, Mitchell WJ, Feldman LT, Martin JR. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J Neurovirol. 1995;1:259-267.
16. Yamamura J, Kageyama S, Uwano T, Kurokawa M, Imakita M, Shiraki K. Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector. Gene Ther. 2000;7:934-941.
17. Sakurai M, Abe K, Hayashi T, et al. In vivo adenovirus-mediated gene transfer and expression in ischemic rabbit spinal cord. J Vasc Surg. 1999;30:542-550.
18. Romero MI, Smith GM. Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Ther. 1998;5:1612-1621.
19. Liu Y, Himes BT, Moul J, et al. Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Res. 1997; 768:19-29.
20. Warita H, Abe K, Setoguchi Y, Itoyama Y. Expression of adenovirus-mediated E. coli lacZ gene in skeletal muscles and spinal motor neurons of transgenic mice with a mutant superoxide dismutase gene. Neurosci Lett. 1998;246:153-156.
21. Boulis NM, Turner DE, Dice JA, Bhatia V, Feldman EL. Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery. 1999;45:131-137; discussion 137-138.
22. Boulis NM, Bhatia V, Brindle TI, et al. Adenoviral nerve growth factor and beta-galactosidase transfer to spinal cord: a behavioral and histological analysis. J Neurosurg. 1999;90:99-108.
23. Mannes AJ, Caudle RM, O'Connell BC, Iadarola MJ. Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration. Brain Res. 1998;793:1-6.
24. Byrnes AP, Rusby JE, Wood MJ, Charlton HM. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 1995; 66:1015-1024.
25. Byrnes AP, Wood MJ, Charlton HM. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 1996;3: 644-651.
26. Byrnes AP, MacLaren RE, Charlton HM. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci. 1996;16:3045-3055.
27. Kajiwara K, Byrnes AP, Charlton HM, Wood MJ, Wood KJ. Immune responses to adenoviral vectors during gene transfer in the brain. Hum Gene Ther. 1997;8:253-265.
28. Wood MJ, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 1996;19:497-501.
29. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther. 1997;8:37-44.
30. Lawrence MS, Foellmer HG, Elsworth JD, et al. Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus. Gene Ther. 1999;6:1368-1379.
31. O'Leary MT, Charlton HM. A model for long-term transgene expression in spinal cord regeneration studies. Gene Ther. 1999;6: 1351-1359.
32. Driesse MJ, Esandi MC, Kros JM, et al. Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther. 2000;7:1401-1409.
33. Stein CS, Ghodsi A, Derksen T, Davidson BL. Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice. J Virol. 1999;73: 3424-3429.
34. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Ther. 1995;2:357-362.
35. During MJ. Adeno-associated virus as a gene delivery system. Adv Drug Deliv Rev. 1997;27:83-94.
36. During MJ, Leone P. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders. Clin Neurosci. 1995;3:292-300.
37. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today. 2000;6:433-440.
38. Carter PJ, Samulski RJ. Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med. 2000;6:17-27.
39. Peel AL, Klein RL. Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods. 2000;98:95-104.
40. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998;72:2224-2232.
41. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther. 1998;9:2745-2760.
42. Grimm D, Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther. 1999;10:2445-2450.
43. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 1997;4:16-24.
44. Hermens WT, ter Brake O, Dijkhuizen PA, et al. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther. 1999;10:1885-1891.
45. Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA. 2000;97:3428-3432.
46. Zhong LT, Sarafian T, Kane DJ, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 1993;90:4533-4537.
47. Zhong LT, Kane DJ, Bredesen DE. BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res Mol Brain Res. 1993;19:353-355.
48. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature. 1995;374:814-816.
49. Lou J, Lenke LG, Xu F, O'Brien M. In vivo Bcl-2 oncogene neuronal expression in the rat spinal cord. Spine. 1998;23:517-523.
50. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci. 1988;8:2394-2405.
51. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 1987;235:214-216.
52. Novikova L, Novikov L, Kellerth JO. Effects of neurotransplants and BDNF on the survival and regeneration of injured adult spinal motoneurons. Eur J Neurosci. 1997;9:2774-2777.
53. Novikov L, Novikova L, Kellerth JO. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience. 1997;79: 765-774.
54. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci. 1997;17:5560-5572.
55. Haase G, Kennel P, Pettmann B, et al. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med. 1997;3:429-436.
56. Arumae U, Pirvola U, Palgi J, et al. Neurotrophins and their receptors in rat peripheral trigeminal system during maxillary nerve growth. J Cell Biol. 1993;122:1053-1065.
57. Houweling DA, Lankhorst AJ, Gispen WH, Bar PR, Joosten EA. Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp Neurol. 1998;153: 49-59.
58. Watanabe M, Sawai H, Fukuda Y. Survival of axotomized retinal ganglion cells in adult mammals. Clin Neurosci. 1997;4:233-239.
59. Gravel C, Gotz R, Lorrain A, Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat Med. 1997;3:765-770.
60. Hagg T, Quon D, Higaki J, Varon S. Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron. 1992;8: 145-158.
61. Baumgartner BJ, Shine HD. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol. 1998;153:102-112.
62. Baumgartner BJ, Shine HD. Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line-derived neurotrophic factor. J Neurosci Res. 1998;54:766-777.
63. Schnell L, Schneider R, Kolbeck R, Barde YA, Schwab ME. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature. 1994; 367:170-173.
64. Oudega M, Hagg T. Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord. Brain Res. 1999; 818:431-438.
65. Liu Y, Himes BT, Solowska J, et al. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp Neurol. 1999;158:9-26.
66. Himes BT, Liu Y, Solowska JM, Snyder EY, Fischer I., Tessler A. Transplant of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats. J Neurosci Res. 2001;65:549-564.
67. Watabe K, Ohashi T, Sakamoto T, et al. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res. 2000;60: 511-519.
68. Liu Y, Kim D, Himes BT, et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci. 1999;19:4370-4387.
69. Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther. 1999; 10: 1251-1257.
70. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA. 1999;96:3211-3216.
71. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 2001;8:551-556.
72. Eaton MJ, Plunkett JA, Martinez MA, et al. Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant. 1999;8:87-101.
73. Rothstein JD, Bristol LA, Hosler B, Brown RH Jr, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA. 1994;91:4155-4159.
74. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277: 559-562.
75. Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum Mol Genet. 2000;9:803-811.